AU2001267851A1 - Oxygen-containing ophthalmic composition - Google Patents

Oxygen-containing ophthalmic composition

Info

Publication number
AU2001267851A1
AU2001267851A1 AU2001267851A AU6785101A AU2001267851A1 AU 2001267851 A1 AU2001267851 A1 AU 2001267851A1 AU 2001267851 A AU2001267851 A AU 2001267851A AU 6785101 A AU6785101 A AU 6785101A AU 2001267851 A1 AU2001267851 A1 AU 2001267851A1
Authority
AU
Australia
Prior art keywords
oxygen
ophthalmic composition
containing ophthalmic
composition
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267851A
Inventor
Toshiki Kurumada
Toru Nishihara
Yoshiomi Soejima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of AU2001267851A1 publication Critical patent/AU2001267851A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001267851A 2000-06-29 2001-06-28 Oxygen-containing ophthalmic composition Abandoned AU2001267851A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-195804 2000-06-29
JP2000195804 2000-06-29
PCT/JP2001/005542 WO2002000228A1 (en) 2000-06-29 2001-06-28 Oxygen-containing ophthalmic composition

Publications (1)

Publication Number Publication Date
AU2001267851A1 true AU2001267851A1 (en) 2002-01-08

Family

ID=18694404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267851A Abandoned AU2001267851A1 (en) 2000-06-29 2001-06-28 Oxygen-containing ophthalmic composition

Country Status (5)

Country Link
US (1) US20020164379A1 (en)
EP (1) EP1295602A1 (en)
CN (1) CN1383383A (en)
AU (1) AU2001267851A1 (en)
WO (1) WO2002000228A1 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6386751B1 (en) 1997-10-24 2002-05-14 Diffusion Dynamics, Inc. Diffuser/emulsifier
US7128278B2 (en) 1997-10-24 2006-10-31 Microdiffusion, Inc. System and method for irritating with aerated water
US7654728B2 (en) * 1997-10-24 2010-02-02 Revalesio Corporation System and method for therapeutic application of dissolved oxygen
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
US7832552B2 (en) * 2002-08-17 2010-11-16 Menicon Co. Ltd. Duo packaging for disposable soft contact lenses using a substrate
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
EP1617277B1 (en) * 2003-04-03 2009-05-27 Seed Co., Ltd. Ophthalmic lenses capable of sustained drug release and preservative solutions therefor
US20050008687A1 (en) * 2003-07-07 2005-01-13 Makoto Yuasa Metal-porphyrin-complex-embedded liposomes, production process thereof, and medicines making use of the same
WO2005032480A2 (en) * 2003-10-03 2005-04-14 Judith Boston Methods, compositions,, apparatuses containing tetrameric oxygen
JP4669837B2 (en) * 2004-03-04 2011-04-13 真 湯浅 Metalloporphyrin complex-embedded niosome, process for producing the same, and medicament using the same
US20050244512A1 (en) * 2004-05-01 2005-11-03 Holekamp Nancy M Ophthalmic fluid and method of delivering same
JP2006020657A (en) * 2004-07-05 2006-01-26 Otsuka Pharmaceut Factory Inc Infusion preparation containing trace elements
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
US20080057023A1 (en) * 2006-08-29 2008-03-06 Chynn Emil W Oxygenated ophthalmic composition
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
JP5306214B2 (en) 2006-10-25 2013-10-02 リバルシオ コーポレイション Mixing equipment
US8597689B2 (en) 2006-10-25 2013-12-03 Revalesio Corporation Methods of wound care and treatment
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
CA2667614A1 (en) 2006-10-25 2008-09-25 Revalesio Corporation Method of wound care and treatment
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
EP1992339A1 (en) * 2007-05-18 2008-11-19 Saeed Sarkar Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
US7879996B2 (en) * 2007-05-18 2011-02-01 Saeed Sarkar Water soluble compounds
US8202272B2 (en) 2007-07-19 2012-06-19 Avedro, Inc. Eye therapy system
US8992516B2 (en) 2007-07-19 2015-03-31 Avedro, Inc. Eye therapy system
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US8545487B2 (en) 2007-12-05 2013-10-01 Avedro Inc. Eye therapy system
US8348935B2 (en) 2008-01-23 2013-01-08 Avedro, Inc. System and method for reshaping an eye feature
US8469952B2 (en) * 2008-01-23 2013-06-25 Avedro, Inc. System and method for positioning an eye therapy device
US8409189B2 (en) * 2008-01-23 2013-04-02 Avedro, Inc. System and method for reshaping an eye feature
CA2723215A1 (en) 2008-05-01 2009-11-05 Revalesio Corporation Compositions and methods for treating digestive disorders
US8398628B2 (en) * 2008-09-19 2013-03-19 Avedro, Inc. Eye therapy system
US8366689B2 (en) 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
JP2012504472A (en) 2008-10-01 2012-02-23 アヴェドロ・インコーポレーテッド Eye treatment system
JP2012508087A (en) 2008-11-11 2012-04-05 アヴェドロ・インコーポレーテッド Eye treatment system
US8712536B2 (en) 2009-04-02 2014-04-29 Avedro, Inc. Eye therapy system
EP2413832A1 (en) * 2009-04-02 2012-02-08 Avedro, INC. Eye therapy system
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
WO2011050164A1 (en) * 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
WO2011053768A2 (en) * 2009-10-30 2011-05-05 Avedro, Inc. System and method for stabilizing corneal tissue after treatment
EP4480461A3 (en) 2010-03-19 2025-02-12 Avedro, Inc. Systems for applying and monitoring eye therapy
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
JP2013533320A (en) 2010-08-12 2013-08-22 レバレジオ コーポレイション Compositions and methods for treating tauopathy
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
JP6368459B2 (en) * 2012-06-14 2018-08-01 松本　高明 Method for producing ophthalmic solution
WO2013059837A2 (en) 2012-07-16 2013-04-25 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
CN102973594B (en) * 2012-12-19 2016-01-20 李洪江 A kind of ophthalmic preparation and preparation method containing oxygen microcapsule
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
JP6644799B2 (en) 2014-10-27 2020-02-12 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． System and method for ocular crosslinking treatment
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
WO2016172695A1 (en) 2015-04-24 2016-10-27 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
EP3297589B1 (en) 2015-05-22 2024-12-18 Avedro Inc. Systems for monitoring cross-linking activity for corneal treatments
CN108025011A (en) 2015-07-21 2018-05-11 艾维德洛公司 With the system and method for photosensitizing agents eyes
CN109788752A (en) * 2016-07-22 2019-05-21 组织测试技术有限公司 It is saved with glycolipid enhancing cell freezing
CN106176806A (en) * 2016-08-29 2016-12-07 安徽艾珂尔制药有限公司 A kind of Kanamycin sulfate eye drops and preparation method thereof
CN106265675A (en) * 2016-08-29 2017-01-04 安徽艾珂尔制药有限公司 A kind of antimicrobial form aciclovir eye drop and preparation method thereof
CA3070172A1 (en) 2017-07-18 2019-01-24 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
AU2019231257B2 (en) 2018-03-05 2024-10-31 Avedro, Inc. System for eye tracking during eye treatment
US11766356B2 (en) 2018-03-08 2023-09-26 Avedro, Inc. Micro-devices for treatment of an eye
EP3852606A4 (en) 2018-09-19 2022-06-22 Avedro Inc. SYSTEMS AND METHODS OF OCULOMETRY DURING OCULAR TREATMENT
CN113316435B (en) 2018-10-09 2024-04-12 艾维德洛公司 Photoactivation system and method for corneal cross-linking treatment
US12171691B2 (en) 2019-02-26 2024-12-24 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
US10561682B1 (en) * 2019-04-01 2020-02-18 Judith Boston Treatment of ischemic conditions, hypoxic conditions, conditions related to a hypoxia-induction factor, or conditions related to reactive oxygen species with oxygen-containing liquids
WO2020206013A1 (en) * 2019-04-01 2020-10-08 Judith Boston Treatment of ischemic conditions, hypoxic conditions, conditions related to a hypoxia-induction factor
KR20210009947A (en) * 2019-07-18 2021-01-27 윤영선 Oxygen-introduced Ophthalmic compound, and a method for producing the same
JP7624433B2 (en) 2019-08-06 2025-01-30 アヴェドロ・インコーポレーテッド Photoactivation system and method for corneal crosslinking treatment
US20210228622A1 (en) * 2020-01-24 2021-07-29 KHJ Biological LLC Compositions of oxyhydrogen and the thereapeutic use thereof for ocular conditions
US11754753B2 (en) * 2020-04-27 2023-09-12 Coopervision International Limited Antioxidant contact lens
WO2024162693A1 (en) * 2023-02-01 2024-08-08 아주대학교산학협력단 Composition for prevention and treatment of inflammatory eye disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
EP0254413A3 (en) * 1986-06-13 1989-11-08 Yoshiaki Matsuo Silver-ionic water and its uses
US5389383A (en) * 1993-06-18 1995-02-14 Allergan, Inc. Method for treating hypoxia-associated ocular complications
CA2195630A1 (en) * 1994-07-22 1996-02-08 Joseph Bonaventura Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof
EP1033124B1 (en) * 1997-10-27 2008-09-10 Otsuka Pharmaceutical Factory, Inc. Packaged ophthalmic perfusate and cleaning fluid bag
FR2776540B1 (en) * 1998-03-27 2000-06-02 Sidel Sa BARRIER-EFFECT CONTAINER AND METHOD AND APPARATUS FOR ITS MANUFACTURING
JP2000175595A (en) * 1998-12-18 2000-06-27 ▲高▼梨 直治 Transportation of live fish

Also Published As

Publication number Publication date
CN1383383A (en) 2002-12-04
WO2002000228A1 (en) 2002-01-03
US20020164379A1 (en) 2002-11-07
EP1295602A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU2001262847A1 (en) Language-understanding
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001258108A1 (en) Improved rubber composition
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001241098A1 (en) Composition
AU2001267878A1 (en) Hypoglycemics
AU2001258924A1 (en) Microsatellite-aflp
AU2001281921A1 (en) Bdellosomes
AU2001275201A1 (en) Acne-treating composition
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2001287852A1 (en) Composition
AU2002214354A1 (en) Neck-phone
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001260192A1 (en) Glycinamides
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001262711A1 (en) Cytoprotectors
AU2001262163A1 (en) Composition
AU2002219846A1 (en) Novel use
AU2001274750A1 (en) Novel beta-hydroxyamides